Non-Betalactam Plant

• Tablet
  Tablet is a mixture of active substances and excipients, usually in powder form, pressed or compacted into a solid. The excipients include binders, glidants (flow aids) and lubricants to ensure efficient tabletting; disintegrants to ensure that the tablet breaks up in the digestive tract; sweeteners or flavors to mask the taste of bad-tasting active ingredients; and pigments to make uncoated tablets visually attractive. A coating may be applied to hide the taste of the tablet’s components, to make the tablet smoother and easier to swallow, and to make it more resistant to the environment, extending its shelf life. Supporting by 4 tablet compression machines provide up to 1.5 million tablets annual output available.


• Hard Capsule
  Hard Capsule is a unique dosage form which consists two empty separate parts of semi-closed cylinder in shape with i.e caps and body which filled with powder which is capable in order of 48 million capsules per year.


• Cream/Ointmen
  Cream is Semisolid dosage forms containing one or more drug substances dissolved or dispersed in a suitable base. The products consists of oil in water emulsions that are water washable and more cosmetically and aesthetically acceptable. In one year, Otto provide you for 1,5 million tubes of cream/ointment.


• Syrup
  Syrup is Liquid preparations, intended for oral administration, that contain one or more substances with or without flavoring, sweetening, or coloring agents dissolved in water or co solvent water mixtures which is capable in order of 13 million capsules per year.


• “Granulated” Syrup (dry syrup)
  Granulated powder formulated for direct oral administration to the patient and dispensed in a more concentrated form that must be diluted prior to administration.


• Injectables Solution
  Injectables products are intended for use by injection under or through layer of the skin or mucous membranes. Since they are directly introduced into internal body compartments, they must be free from microbial contamination and from toxic components as well as possess an exceptionally high level of purity. Therefore, all components and all processes involved in the preparation of these products must be designed to eliminate as much as possible, contamination of all types whether of physical, chemical or microbiological origin.

PT Otto builds new injectables manufacturing facilities of ampoule packed sterile liquids, presenting an advanced technology & cGMP comply plant those will supply an 12.5 million ampoules per annum.